Lidocaïne Vaselinecrème Tiofarma (Lidocaine)

Lidocaine works by binding to voltage‑gated sodium channels on nerve cells, stabilising them in an inactive state. This blocks the rapid influx of sodium ions needed for nerve impulse generation, resulting in a reversible loss of sensation and analgesia at the site where the cream is applied.

The appropriate dose and frequency are determined by the prescribing healthcare professional based on the severity of the condition, patient age and other clinical factors. Patients should follow the prescriber’s instructions and not exceed the recommended amount.

Safety data for rectal lidocaine cream in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lidocaïne Vaselinecrème Tiofarma contains lidocaine, an amide‑type local anesthetic, which offers rapid onset and reliable analgesia. Compared with benzocaine or prilocaine creams, lidocaine generally provides a longer duration of action and a lower risk of methemoglobinemia, making it a preferred choice for anorectal applications.

Store the cream at room temperature, below 25 °C, in its original packaging. Protect it from moisture, direct sunlight and extreme temperatures. Keep the container tightly closed when not in use to maintain product stability.

The cream is applied rectally using a clean fingertip or applicator. A thin layer is spread over the affected area as directed by the prescriber, typically after gentle cleaning of the region. Do not insert the cream deep into the anal canal unless instructed.

Serious risks include allergic reactions such as urticaria or angioedema, severe dermatitis, systemic toxicity manifesting as central nervous system symptoms (e.g., dizziness, seizures), and rare cases of methemoglobinemia. Any signs of systemic effects or severe local reactions should prompt immediate medical attention.

Individuals with a known hypersensitivity to lidocaine, other amide‑type local anesthetics, or any component of the formulation should avoid using this product. It is also contraindicated in patients with severe liver disease that may impair lidocaine metabolism, unless a healthcare professional advises otherwise.